Company intelligence / Profile preview

BioHyaluronic Solutions

Ownership: Private
Development stage: Other

Overview

BioHyaluronic Solutions is a biotechnology company focused on developing advanced hyaluronic acid (HA) based products for therapeutic and aesthetic applications. The company leverages a proprietary cross-linking platform to enhance the stability and biocompatibility of HA hydrogels, aiming to improve outcomes in orthopedics and dermatology. Their primary research focuses on long-acting viscosupplementation for osteoarthritis and next-generation dermal fillers with superior integration. By optimizing the molecular weight and degradation profiles of HA, BioHyaluronic Solutions seeks to provide sustained relief and regenerative benefits across multiple medical fields.

Therapeutic areas: OphthalmologyRheumatologyDermatology
Modalities: Hydrogel-based drug delivery therapyBiologicPolymer-drug conjugate therapy
Industry: Biotech

Beyond the preview

Go deeper on BioHyaluronic Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioHyaluronic Solutions.

Explore the full profile